MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

MDT

88.44

-1.53%↓

VEEV

227.74

-1.64%↓

A

113.65

-2.76%↓

HQY

87.08

-1.46%↓

PDCO

31.26

0%↓

Search

NeoGenomics Inc

Suletud

9.36 -1.68

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

9.03

Max

9.62

Põhinäitajad

By Trading Economics

Sissetulek

2.4M

-15M

Müük

4.2M

172M

Aktsiakasum

0.04

Kasumimarginaal

-8.909

Töötajad

2,200

EBITDA

1.9M

3.7M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+87.36% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

29. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-357M

1.2B

Eelmine avamishind

11.04

Eelmine sulgemishind

9.36

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

25. märts 2025, 20:31 UTC

Tulu

GameStop Posts Higher 4Q Profit on Fewer Expenses

25. märts 2025, 17:03 UTC

Tulu
Suurimad hinnamuutused turgudel

BitFuFu Shares Jump 22% After 2024 Revenue Surges on Cloud-Mining Business

1. apr 2025, 13:46 UTC

Market Talk

Bitcoin Reaction to Tariffs Seen Varying Widely -- Market Talk

1. apr 2025, 10:16 UTC

Market Talk

Crypto Uptake in Cross-Border Payments Remains Low -- Market Talk

1. apr 2025, 08:00 UTC

Market Talk

Bitcoin Recovers Slightly Ahead of U.S. Tariffs -- Market Talk

31. märts 2025, 15:06 UTC

Omandamised, ülevõtmised, äriostud

MicroStrategy Buys $1.9 Billion of Bitcoin as Paper Profits Erode -- Barrons.com

31. märts 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

Business Led by Two of the president's Sons Will Fold Into American Bitcoin -- WSJ

31. märts 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

Move Will Add to Trump Family's Expanding Portfolio of Cryptocurrency Businesses -- WSJ

31. märts 2025, 09:30 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

The Trump Family Advances Its All-Out Crypto Blitz, This Time With Bitcoin Mining -- WSJ

31. märts 2025, 09:30 UTC

Omandamised, ülevõtmised, äriostud

Eric Trump and Donald Trump Jr. Are Investing in a Bitcoin-Mining Company -- WSJ

31. märts 2025, 07:32 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

31. märts 2025, 07:32 UTC

Market Talk

Bitcoin Falls as Trump Tariff Remarks Hit Sentiment -- Market Talk

31. märts 2025, 07:32 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

28. märts 2025, 14:56 UTC

Tulu
Omandamised, ülevõtmised, äriostud

MicroStrategy Sells Preferred Stock to Buy Bitcoin. Why It Deserves a Look. -- Barrons.com

28. märts 2025, 09:26 UTC

Market Talk

Bitcoin Falls as Tariff Concerns Weigh -- Market Talk

28. märts 2025, 08:20 UTC

Market Talk

Financial Services Roundup: Market Talk

27. märts 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

27. märts 2025, 19:13 UTC

Market Talk

More U.S. States Eyeing Crypto as an Investment -- Market Talk

27. märts 2025, 10:08 UTC

Market Talk

Bitcoin Rises Slightly as Traders Digest Tariff News -- Market Talk

26. märts 2025, 17:23 UTC

Tulu

GameStop Has a Pile of Cash. Its Bitcoin Play Is a Hit, for Now. -- Barrons.com

26. märts 2025, 15:09 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin, XRP, and Other Crypto Prices Drop After Getting a GameStop Boost -- Barrons.com

26. märts 2025, 09:17 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin, XRP and Other Crypto Prices Get a GameStop Boost -- Barrons.com

26. märts 2025, 08:08 UTC

Market Talk

Bitcoin Edges Higher on Cautious Optimism Over Tariffs -- Market Talk

25. märts 2025, 19:33 UTC

Peamised uudised

Trump Family Venture Plunges Deeper Into Crypto With New 'Stablecoin' -- Update

25. märts 2025, 14:07 UTC

Peamised uudised

Trump-Backed World Liberty Financial Unveils Plans for New Stablecoin -- WSJ

25. märts 2025, 09:12 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

25. märts 2025, 09:12 UTC

Market Talk

Global Equities Roundup: Market Talk

25. märts 2025, 09:12 UTC

Market Talk

Bitcoin Falls as Risk Rally on Trade Optimism Fades -- Market Talk

24. märts 2025, 08:46 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

24. märts 2025, 08:46 UTC

Market Talk

Bitcoin Rises on Hopes For Less Stringent U.S. Tariffs -- Market Talk

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

87.36% tõus

12 kuu keskmine prognoos

Keskmine 17.78 USD  87.36%

Kõrge 19 USD

Madal 16 USD

Põhineb 14 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

10

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.39 / 9.91Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Strong Bearish Evidence

Pikk perspektiiv

Strong Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.